Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia - Related Studies

Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia

This study is ongoing, but not recruiting participants.

Study NCT00006363. Last updated on October 24, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Leukemia

2	Additional conditions recognized in this trial
		Leukemia, Myeloid
		Leukemia, Myeloid, Acute

3	More general conditions related to this trial
		Neoplasms
		Neoplasms by Histologic Type

4	Interventions listed in this trial
		aldesleukin
		busulfan
		cytarabine
		daunorubicin hydrochloride
		etoposide
		filgrastim

5	Additional drug interventions recognized in this trial
		Daunorubicin

6	More general drug interventions related to this trial
		Anti-HIV Agents
		Anti-Infective Agents
		Anti-Retroviral Agents
		Antibiotics, Antineoplastic
		Antimetabolites
		Antimetabolites, Antineoplastic
		Antineoplastic Agents
		Antiviral Agents
		Immunologic Factors
		Immunosuppressive Agents
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Physiological Effects of Drugs
		Therapeutic Uses

7	Sponsors listed in this trial
		Cancer and Leukemia Group B
		National Cancer Institute (NCI)